Bio-pharmaceutical company to explore collaboration opportunities during largest U.S. government-led trade and business development event Rockville, MD – March 7, 2023 – Tasly Pharmaceuticals, Inc. (Tasly U.S.), “dedicated to a healthier world,” will participate in the Trade Winds ASEAN Mission and Business Forum March 13-15 in Bangkok, Thailand. The Trade Winds event, organized by the […]
Bio-pharmaceutical company to join with Maryland-based organizations at Asia’s premier biotechnology partnering event Rockville, MD – October 5, 2022 – Tasly Pharmaceuticals, Inc. (Tasly U.S.), “dedicated to a healthier world,” will join a delegation of other Maryland-based bio-pharmaceutical companies at BioJapan 2022, Asia’s premier partnering event for the global biotechnology sector, in Yokohama, Japan, October […]
We invite you to consider collaborating with Tasly U.S. if you are interested in shaping the future of medicine and enhancing the quality of life for individuals in the United States and globally. Our primary focus is on botanical medicine’s ultimate potential, and we aim to integrate practices refined over thousands of years into modern […]
Tests show it can reduce chronic stable angina. Tasly Pharmaceuticals Inc(Tasly US), is nearing the end of what has been a long road of testing to get approval from the US Food and Drug Administration (FDA) for its T89 drug (Dantonic), multiple components innovative Chinese Medicine (ICM). Dantonic, the drug has been shown to have few […]
Tasly Pharmaceutical Group Co., Ltd. (referred to as “Tasly”) and the US-based drug maker Azurity Pharmaceuticals, Inc. (referred to as “Azurity”) announced on Sep. 6 comprehensive cooperation in the R&D and marketing of T89 in the States. According to their agreement, Azurity will contribute an amount up to US$23 million for T89-related clinical research and […]
ROCKVILLE, MD – Tasly Pharmaceuticals Co. Ltd. of China and Tasly Pharmaceuticals, Inc. of USA, a global leader in pharmaceuticals, biologics and nutraceuticals, announced that its three-herb composition drug T89 (Dantonic), has been shown in a Phase 3 global clinical trial to improve Treadmill exercise duration (TED) and more effectively reduce the frequency of chronic […]
On March 12, 2018, Dr. Henry Sun, Ph.D., and CEO/President of Tasly Pharmaceuticals, Inc. took the stage at this year’s American College of Cardiology (ACC) conference as a keynote speaker to present on a new topic. He spoke about the future of herbal therapies to support heart disease treatments, citing a recent completion of a […]
To Our Valued Customers, Patients, Healthcare Providers, and Business Partners, On February 3, 2015, the New York State Attorney General’s Office accused four national retailers of selling dietary supplements that were fraudulent and in many cases contaminated with unlisted ingredients. Although we cannot comment on this and will not make any assumptions of what is […]
Rockville, MD – PR Newswire – 27 August 2014 – On September 3, 2014, Tasly Pharmaceuticals, Inc., a global leader in Pharmaceuticals, Biologics, and Nutraceuticals, hosted a ribbon-cutting event at its corporate headquarters in Rockville, Maryland. The ceremony included over 150 distinguished guests and dignitaries, including Tasly’s corporate leaders, Maryland state officials, high-level media representatives, […]